AptarGroup CEO Stephan Tanda discussed on 'The Exchange' that the demand for pharmaceutical consumer goods remains strong post-COVID, although there are some areas of weakness in consumer goods, with travel significantly boosting the beauty and skincare s 00:10:00

Share On Facebook Share On Twitter

Stephan Tanda joined Aptar in February 2017 as President and CEO. Prior to joining Aptar, Stephan served as an Executive Managing Board Director at Royal DSM NV and oversaw its $6 billion global Nutrition business as well as its Pharma joint ventures and business interests in the Americas. Stephan has lived and worked in seven countries while working for DuPont, Freudenberg Nonwovens Group and DSM. Over his career, Stephan has focused on developing local and global talent, building sustainable businesses and organizations while successfully delivering increased shareholder value, sales and profits, both via organic growth and via some 15 acquisitions and joint ventures. In addition to Aptar, Stephan serves on the board of Ingredion as an Independent Director and previously served on the boards of Patheon NV and Semperit AG.

Recent Videos